GC Biopharma Corp. Stock Price & Chart

KRX: 006280 · 녹십자 · KOSPI

₩123,800▲ ₩100 (+0.08%)at close · July 27, 2026
183,800115,900123,800Jul 03, 25Oct 10Jan 14Apr 20Jul 27, 26

GC Biopharma Corp. (녹십자, KRX: 006280) last closed at ₩123,800 on July 27, 2026, a +0.08% move on the day. Over the trailing 52 weeks the stock has traded between ₩115,900 and ₩183,800, a -7.20% change over the past year. Figures are end-of-day closing prices from the Korea Exchange.

Last close₩123,800
Day change+0.08%
52-week high₩183,800
52-week low₩115,900

Key Fundamentals

FY 2026.03
Market cap₩1.45T
P/E (PER)-309.25
P/B (PBR)1.16
EPS₩-400
BPS₩106,673
ROE-1.12%
Debt ratio112.06%
Rev. growth13.49%

P/E, P/B and market cap are computed from the latest close; EPS, BPS, ROE and debt ratio are the most recent reported figures (FY 2026.03) from the Korea Investment & Securities Open API. Informational only, not investment advice.

Technical Snapshot

as of 2026-07-27
Weak BearishAlgorithmic summary of 5 standard indicators (net score -1). Describes current technical posture only — not a buy or sell recommendation.
  • ▲ Bullish20-day MAPrice above 122,050
  • ▼ Bearish60-day MAPrice below 128,940
  • ▼ Bearish120-day MAPrice below 141,513
  • ▼ BearishMA trend (20 vs 60)Short-term below mid-term
  • · NeutralRSI (14)RSI 52 — neutral zone
  • ▲ BullishMACD (12,26,9)MACD above signal
52-week position: 12% of rangeRSI(14): 525-day volume vs 20-day: -2%

Indicators are computed mechanically from end-of-day prices. They are provided for informational purposes only, are not investment advice or a recommendation, and past performance does not indicate future results.

Reports mentioning GC Biopharma Corp.

No daily reports have covered GC Biopharma Corp. yet. New reports appear here automatically when the stock is featured.

← Back to all Korean stocks

Price history is sourced from the Korea Exchange via the Korea Investment & Securities Open API and updated after each trading session. This page is provided for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Data may be delayed or contain errors — verify with an official source before trading.